{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:58:39Z","timestamp":1792166319316,"version":"4.4.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472157, 82302273, 92359304, 82330060, 82473791, 82150203, 32201127, 82270113, T2522033"],"award-info":[{"award-number":["82472157, 82302273, 92359304, 82330060, 82473791, 82150203, 32201127, 82270113, T2522033"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20230839, BK20250102"],"award-info":[{"award-number":["BK20230839, BK20250102"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Specialized Research Funds from the State Key Laboratory of Natural Medicines, China Pharmaceutical University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-68490-5","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T11:37:11Z","timestamp":1768995431000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["In situ self-assembled cell reservoir hydrogel for maneuvering multistage radioimmunotherapy"],"prefix":"10.1038","volume":"17","author":[{"given":"Yue","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinge","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingguang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9517-1325","authenticated-orcid":false,"given":"Longguang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5041-7865","authenticated-orcid":false,"given":"Shenghong","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5057-3873","authenticated-orcid":false,"given":"Wenpei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"68490_CR1","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/med.21998","volume":"44","author":"X Kong","year":"2024","unstructured":"Kong, X. et al. Revolutionizing the battle against locally advanced breast cancer: a comprehensive insight into neoadjuvant radiotherapy. Med. Res. Rev. 44, 606\u2013631 (2024).","journal-title":"Med. Res. Rev."},{"key":"68490_CR2","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41571-022-00697-z","volume":"19","author":"MC Vozenin","year":"2022","unstructured":"Vozenin, M. C., Bourhis, J. & Durante, M. Towards clinical translation of FLASH radiotherapy. Nat. Rev. Clin. Oncol. 19, 791\u2013803 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"68490_CR3","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1093\/nar\/gkad076","volume":"51","author":"G Yi","year":"2023","unstructured":"Yi, G. et al. DNA polymerase \u03b8-mediated repair of high LET radiation-induced complex DNA double-strand breaks. Nucleic Acids Res. 51, 2257\u20132269 (2023).","journal-title":"Nucleic Acids Res."},{"key":"68490_CR4","first-page":"65","volume":"67","author":"FG Herrera","year":"2017","unstructured":"Herrera, F. G., Bourhis, J. & Coukos, G. Radiotherapy combination opportunities leveraging immunity for the next oncology practice. CA Cancer J. Clin. 67, 65\u201385 (2017).","journal-title":"CA Cancer J. Clin."},{"key":"68490_CR5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.semcancer.2023.11.006","volume":"98","author":"C Beckers","year":"2024","unstructured":"Beckers, C., Pruschy, M. & Vetrugno, I. Tumor hypoxia and radiotherapy: a major driver of resistance even for novel radiotherapy modalities. Semin Cancer Biol. 98, 19\u201330 (2024).","journal-title":"Semin Cancer Biol."},{"key":"68490_CR6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen, Z., Han, F., Du, Y., Shi, H. & Zhou, W. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct. Target Ther. 8, 70 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"68490_CR7","volume":"22","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. Synergistic cerium oxide nanozymes: targeting DNA damage and alleviating tumor hypoxia for improved NSCLC radiotherapy efficiency. J. Nanobiotechnol. 22, 25 (2024).","journal-title":"J. Nanobiotechnol."},{"key":"68490_CR8","doi-asserted-by":"crossref","first-page":"101151","DOI":"10.1016\/j.xcrm.2023.101151","volume":"4","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. CD39 inhibition and VISTA blockade may overcome radiotherapy resistance by targeting exhausted CD8+ T cells and immunosuppressive myeloid cells. Cell Rep. Med. 4, 101151 (2023).","journal-title":"Cell Rep. Med."},{"key":"68490_CR9","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.canlet.2015.03.003","volume":"368","author":"E Persa","year":"2015","unstructured":"Persa, E., Balogh, A., S\u00e1fr\u00e1ny, G. & Lumniczky, K. The effect of ionizing radiation on regulatory T cells in health and disease. Cancer Lett. 368, 252\u2013261 (2015).","journal-title":"Cancer Lett."},{"key":"68490_CR10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2020.06.017","volume":"326","author":"M Esmaily","year":"2020","unstructured":"Esmaily, M. et al. Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine. J. Control Release 326, 63\u201374 (2020).","journal-title":"J. Control Release"},{"key":"68490_CR11","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"Ribas, A. & Wolchok, J. D. Cancer immunotherapy using checkpoint blockade. Science 359, 1350\u20131355 (2018).","journal-title":"Science"},{"key":"68490_CR12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.tips.2019.11.003","volume":"41","author":"Y Liu","year":"2020","unstructured":"Liu, Y. & Zheng, P. Preserving the CTLA-4 checkpoint for safer and more effective cancer immunotherapy. Trends Pharm. Sci. 41, 4\u201312 (2020).","journal-title":"Trends Pharm. Sci."},{"key":"68490_CR13","doi-asserted-by":"crossref","first-page":"e007785","DOI":"10.1136\/jitc-2023-007785","volume":"11","author":"KA Jenkins","year":"2023","unstructured":"Jenkins, K. A. et al. XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer. J. Immunother. Cancer 11, e007785 (2023).","journal-title":"J. Immunother. Cancer"},{"key":"68490_CR14","doi-asserted-by":"crossref","first-page":"eabn8097","DOI":"10.1126\/sciimmunol.abn8097","volume":"7","author":"KM van Pul","year":"2022","unstructured":"van Pul, K. M. et al. Local delivery of low-dose anti-CTLA-4 to the melanoma lymphatic basin leads to systemic T(reg) reduction and effector T cell activation. Sci. Immunol. 7, eabn8097 (2022).","journal-title":"Sci. Immunol."},{"key":"68490_CR15","volume":"13","author":"EF Davis-Marcisak","year":"2021","unstructured":"Davis-Marcisak, E. F. et al. Transfer learning between preclinical models and human tumors identifies a conserved NK cell activation signature in anti-CTLA-4 responsive tumors. Genome Med. 13, 129 (2021).","journal-title":"Genome Med."},{"key":"68490_CR16","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41591-018-0232-2","volume":"24","author":"SC Formenti","year":"2018","unstructured":"Formenti, S. C. et al. Radiotherapy induces responses of lung cancer to CTLA-4 blockade. Nat. Med. 24, 1845\u20131851 (2018).","journal-title":"Nat. Med."},{"key":"68490_CR17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.trecan.2021.10.003","volume":"8","author":"KB Pointer","year":"2022","unstructured":"Pointer, K. B., Pitroda, S. P. & Weichselbaum, R. R. Radiotherapy and immunotherapy: open questions and future strategies. Trends Cancer 8, 9\u201320 (2022).","journal-title":"Trends Cancer"},{"key":"68490_CR18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","volume":"20","author":"A Kalbasi","year":"2020","unstructured":"Kalbasi, A. & Ribas, A. Tumour-intrinsic resistance to immune checkpoint blockade. Nat. Rev. Immunol. 20, 25\u201339 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"68490_CR19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.0105-2896.2004.00214.x","volume":"202","author":"CL Langrish","year":"2004","unstructured":"Langrish, C. L. et al. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol. Rev. 202, 96\u2013105 (2004).","journal-title":"Immunol. Rev."},{"key":"68490_CR20","doi-asserted-by":"crossref","first-page":"575597","DOI":"10.3389\/fimmu.2020.575597","volume":"11","author":"KG Nguyen","year":"2020","unstructured":"Nguyen, K. G. et al. Localized interleukin-12 for cancer immunotherapy. Front. Immunol. 11, 575597 (2020).","journal-title":"Front. Immunol."},{"key":"68490_CR21","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1182\/blood.V89.5.1612","volume":"89","author":"W Ertel","year":"1997","unstructured":"Ertel, W. et al. Inhibition of the defense system stimulating interleukin-12 interferon-gamma pathway during critical Illness. Blood 89, 1612\u20131620 (1997).","journal-title":"Blood"},{"key":"68490_CR22","doi-asserted-by":"crossref","first-page":"e009302","DOI":"10.1136\/jitc-2024-009302","volume":"12","author":"F Azar","year":"2024","unstructured":"Azar, F. et al. TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody, favors tumor regression via profound immune remodeling of the tumor microenvironment. J. Immunother. Cancer 12, e009302 (2024).","journal-title":"J. Immunother. Cancer"},{"key":"68490_CR23","doi-asserted-by":"crossref","first-page":"8835","DOI":"10.1200\/JCO.2005.02.1691","volume":"23","author":"CF Eisenbeis","year":"2005","unstructured":"Eisenbeis, C. F. et al. Phase I study of the sequential combination of interleukin-12 and interferon alfa-2b in advanced cancer: evidence for modulation of interferon signaling pathways by interleukin-12. J. Clin. Oncol. 23, 8835\u20138844 (2005).","journal-title":"J. Clin. Oncol."},{"key":"68490_CR24","doi-asserted-by":"crossref","first-page":"e2000349","DOI":"10.1002\/adhm.202000349","volume":"9","author":"MG Raucci","year":"2020","unstructured":"Raucci, M. G., D\u2019Amora, U., Ronca, A. & Ambrosio, L. Injectable functional biomaterials for minimally invasive surgery. Adv. Health. Mater. 9, e2000349 (2020).","journal-title":"Adv. Health. Mater."},{"key":"68490_CR25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41578-018-0023-x","volume":"3","author":"GS Hussey","year":"2018","unstructured":"Hussey, G. S., Dziki, J. L. & Badylak, S. F. Extracellular matrix-based materials for regenerative medicine. Nat. Rev. Mater. 3, 159\u2013173 (2018).","journal-title":"Nat. Rev. Mater."},{"key":"68490_CR26","doi-asserted-by":"crossref","first-page":"e2210707","DOI":"10.1002\/adma.202210707","volume":"36","author":"BH Shan","year":"2024","unstructured":"Shan, B. H. & Wu, F. G. Hydrogel-based growth factor delivery platforms: strategies and recent advances. Adv. Mater. 36, e2210707 (2024).","journal-title":"Adv. Mater."},{"key":"68490_CR27","doi-asserted-by":"crossref","first-page":"122388","DOI":"10.1016\/j.biomaterials.2023.122388","volume":"303","author":"D Zhang","year":"2023","unstructured":"Zhang, D. et al. Architecturally designed sequential-release hydrogels. Biomaterials 303, 122388 (2023).","journal-title":"Biomaterials"},{"key":"68490_CR28","doi-asserted-by":"crossref","first-page":"630","DOI":"10.18063\/ijb.v9i1.630","volume":"9","author":"J Xu","year":"2023","unstructured":"Xu, J. et al. A 3D bioprinted tumor model fabricated with gelatin\/sodium alginate\/decellularized extracellular matrix bioink. Int. J. Bioprint 9, 630 (2023).","journal-title":"Int. J. Bioprint"},{"key":"68490_CR29","doi-asserted-by":"crossref","first-page":"120953","DOI":"10.1016\/j.carbpol.2023.120953","volume":"315","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Highly conductive and tough polyacrylamide\/sodium alginate hydrogel with uniformly distributed polypyrrole nanospheres for wearable strain sensors. Carbohydr. Polym. 315, 120953 (2023).","journal-title":"Carbohydr. Polym."},{"key":"68490_CR30","doi-asserted-by":"crossref","first-page":"102744","DOI":"10.1016\/j.cis.2022.102744","volume":"307","author":"A Karim","year":"2022","unstructured":"Karim, A. et al. Alginate-based nanocarriers for the delivery and controlled-release of bioactive compounds. Adv. Colloid Interface Sci. 307, 102744 (2022).","journal-title":"Adv. Colloid Interface Sci."},{"key":"68490_CR31","doi-asserted-by":"crossref","first-page":"118399","DOI":"10.1016\/j.carbpol.2021.118399","volume":"270","author":"NM Sanchez-Ballester","year":"2021","unstructured":"Sanchez-Ballester, N. M., Bataille, B. & Soulairol, I. Sodium alginate and alginic acid as pharmaceutical excipients for tablet formulation: structure-function relationship. Carbohydr. Polym. 270, 118399 (2021).","journal-title":"Carbohydr. Polym."},{"key":"68490_CR32","first-page":"695","volume":"27","author":"FS Ajayebi","year":"2024","unstructured":"Ajayebi, F. S., Hassanzadeh Nemati, N., Hatamirad, A., Ghazli, M. & Attaran, N. Design and fabrication of alginate hydrogel nanohybrid as a promising cancer treatment. Iran. J. Basic Med. Sci. 27, 695\u2013705 (2024).","journal-title":"Iran. J. Basic Med. Sci."},{"key":"68490_CR33","doi-asserted-by":"crossref","first-page":"126454","DOI":"10.1016\/j.ijbiomac.2023.126454","volume":"253","author":"P Chen","year":"2023","unstructured":"Chen, P. et al. Photo-crosslinking modified sodium alginate hydrogel for targeting delivery potential by NO response. Int. J. Biol. Macromol. 253, 126454 (2023).","journal-title":"Int. J. Biol. Macromol."},{"key":"68490_CR34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10856-021-06619-2","volume":"32","author":"S Wang","year":"2021","unstructured":"Wang, S. et al. Continuous and controllable electro-fabrication of antimicrobial copper-alginate dressing for infected wounds treatment. J. Mater. Sci. Mater. Med. 32, 143 (2021).","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"68490_CR35","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3390\/antiox13060629","volume":"13","author":"D Melo","year":"2024","unstructured":"Melo, D. et al. Catalase, glutathione peroxidase, and peroxiredoxin 2 in erythrocyte cytosol and membrane in hereditary spherocytosis, sickle cell disease, and \u03b2-thalassemia. Antioxidants 13, 629 (2024).","journal-title":"Antioxidants"},{"key":"68490_CR36","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1182\/blood-2021-153836","volume":"138","author":"HN Colvin","year":"2021","unstructured":"Colvin, H. N. et al. An ex vivo model of oxidatively stressed red blood cells demonstrates a role for exogenous amino acids in enhancing red blood cell function and morphology. Blood 138, 922\u2013922 (2021).","journal-title":"Blood"},{"key":"68490_CR37","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","volume":"108","author":"CM Hu","year":"2011","unstructured":"Hu, C. M. et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc. Natl. Acad. Sci. USA 108, 10980\u201310985 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68490_CR38","doi-asserted-by":"crossref","first-page":"13041","DOI":"10.1021\/acsnano.1c02147","volume":"15","author":"Z Zhao","year":"2021","unstructured":"Zhao, Z. et al. Capturing magnesium ions via microfluidic hydrogel microspheres for promoting cancellous bone regeneration. ACS Nano 15, 13041\u201313054 (2021).","journal-title":"ACS Nano"},{"key":"68490_CR39","doi-asserted-by":"crossref","first-page":"17421","DOI":"10.1021\/acs.inorgchem.0c02714","volume":"59","author":"R Zhou","year":"2020","unstructured":"Zhou, R. et al. Site occupancies, VUV-UV-vis photoluminescence, and X-ray radioluminescence of Eu(2\u2009+\u2009)-doped RbBaPO(4). Inorg. Chem. 59, 17421\u201317429 (2020).","journal-title":"Inorg. Chem."},{"key":"68490_CR40","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.biomaterials.2015.08.038","volume":"71","author":"J Wang","year":"2015","unstructured":"Wang, J. et al. BaHoF5 nanoprobes as high-performance contrast agents for multi-modal CT imaging of ischemic stroke. Biomaterials 71, 110\u2013118 (2015).","journal-title":"Biomaterials"},{"key":"68490_CR41","doi-asserted-by":"crossref","first-page":"22015","DOI":"10.1021\/acsnano.3c08625","volume":"17","author":"X Zhao","year":"2023","unstructured":"Zhao, X. et al. Injectable antiswelling and high-strength bioactive hydrogels with a wet adhesion and rapid gelling process to promote sutureless wound closure and scar-free repair of infectious wounds. ACS Nano 17, 22015\u201322034 (2023).","journal-title":"ACS Nano"},{"key":"68490_CR42","doi-asserted-by":"crossref","first-page":"15342","DOI":"10.1002\/anie.201907670","volume":"59","author":"M V\u00e1zquez-Gonz\u00e1lez","year":"2020","unstructured":"V\u00e1zquez-Gonz\u00e1lez, M. & Willner, I. Stimuli-responsive biomolecule-based hydrogels and their applications. Angew. Chem. Int. Ed. Engl. 59, 15342\u201315377 (2020).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"68490_CR43","doi-asserted-by":"crossref","first-page":"122173","DOI":"10.1016\/j.carbpol.2024.122173","volume":"338","author":"T Behroozi Kohlan","year":"2024","unstructured":"Behroozi Kohlan, T., Wen, Y., Mini, C. & Finne-Wistrand, A. Schiff base crosslinked hyaluronic acid hydrogels with tunable and cell instructive time-dependent mechanical properties. Carbohydr. Polym. 338, 122173 (2024).","journal-title":"Carbohydr. Polym."},{"key":"68490_CR44","doi-asserted-by":"crossref","first-page":"122253","DOI":"10.1016\/j.carbpol.2024.122253","volume":"339","author":"T Chen","year":"2024","unstructured":"Chen, T. et al. Rationally designed \u03b2-cyclodextrin-crosslinked polyacrylamide hydrogels for cell spheroid formation and 3D tumor model construction. Carbohydr. Polym. 339, 122253 (2024).","journal-title":"Carbohydr. Polym."},{"key":"68490_CR45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3892\/ijmm.2021.5072","volume":"49","author":"L Sun","year":"2022","unstructured":"Sun, L. et al. Herceptin induces ferroptosis and mitochondrial dysfunction in H9c2 cells. Int. J. Mol. Med. 49, 17 (2022).","journal-title":"Int. J. Mol. Med."},{"key":"68490_CR46","doi-asserted-by":"crossref","first-page":"e1802228","DOI":"10.1002\/adma.201802228","volume":"31","author":"Q Chen","year":"2019","unstructured":"Chen, Q. et al. Nanoparticle-enhanced radiotherapy to trigger robust cancer immunotherapy. Adv. Mater. 31, e1802228 (2019).","journal-title":"Adv. Mater."},{"key":"68490_CR47","first-page":"1183","volume":"4","author":"RJ Motzer","year":"1998","unstructured":"Motzer, R. J. et al. Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma. Clin. Cancer Res. 4, 1183\u20131191 (1998).","journal-title":"Clin. Cancer Res."},{"key":"68490_CR48","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13046-021-02000-x","volume":"40","author":"I Telarovic","year":"2021","unstructured":"Telarovic, I., Wenger, R. H. & Pruschy, M. Interfering with tumor hypoxia for radiotherapy optimization. J. Exp. Clin. Cancer Res. 40, 197 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"68490_CR49","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.3390\/cancers12102860","volume":"12","author":"F Torrisi","year":"2020","unstructured":"Torrisi, F. et al. The role of hypoxia and SRC tyrosine kinase in glioblastoma invasiveness and radioresistance. Cancers 12, 2860 (2020).","journal-title":"Cancers"},{"key":"68490_CR50","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.gendis.2023.02.039","volume":"11","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y., Xing, C., Deng, Y., Ye, C. & Peng, H. HIF-1\u03b1 signaling: essential roles in tumorigenesis and implications in targeted therapies. Genes Dis. 11, 234\u2013251 (2024).","journal-title":"Genes Dis."},{"key":"68490_CR51","doi-asserted-by":"crossref","first-page":"eabo7868","DOI":"10.1126\/sciadv.abo7868","volume":"9","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. Maintaining hypoxia environment of subchondral bone alleviates osteoarthritis progression. Sci. Adv. 9, eabo7868 (2023).","journal-title":"Sci. Adv."},{"key":"68490_CR52","doi-asserted-by":"crossref","first-page":"103205","DOI":"10.1016\/j.redox.2024.103205","volume":"73","author":"W Dai","year":"2024","unstructured":"Dai, W. et al. Hypoxia and the endometrium: an indispensable role for HIF-1\u03b1 as therapeutic strategies. Redox Biol. 73, 103205 (2024).","journal-title":"Redox Biol."},{"key":"68490_CR53","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1158\/1078-0432.CCR-23-3206","volume":"30","author":"Y Hou","year":"2024","unstructured":"Hou, Y. et al. Radiotherapy enhances metastasis through immune suppression by inducing PD-L1 and MDSC in distal sites. Clin. Cancer Res. 30, 1945\u20131958 (2024).","journal-title":"Clin. Cancer Res."},{"key":"68490_CR54","doi-asserted-by":"crossref","first-page":"e20232101","DOI":"10.1084\/jem.20232101","volume":"221","author":"L Wang","year":"2024","unstructured":"Wang, L. et al. Radiotherapy and immunology. J. Exp. Med. 221, e20232101 (2024).","journal-title":"J. Exp. Med."},{"key":"68490_CR55","doi-asserted-by":"crossref","first-page":"e2023739118","DOI":"10.1073\/pnas.2023739118","volume":"118","author":"M Tekguc","year":"2021","unstructured":"Tekguc, M., Wing, J. B., Osaki, M. & Long, J. Sakaguchi S. Treg-expressed CTLA-4 depletes CD80\/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells. Proc. Natl. Acad. Sci. USA 118, e2023739118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68490_CR56","first-page":"488","volume":"68","author":"DA Mahvi","year":"2018","unstructured":"Mahvi, D. A., Liu, R., Grinstaff, M. W., Colson, Y. L. & Raut, C. P. Local cancer recurrence: the realities, challenges, and opportunities for new therapies. CA Cancer J. Clin. 68, 488\u2013505 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"68490_CR57","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s13238-020-00707-9","volume":"11","author":"Q Liu","year":"2020","unstructured":"Liu, Q., Sun, Z. & Chen, L. Memory T cells: strategies for optimizing tumor immunotherapy. Protein Cell 11, 549\u2013564 (2020).","journal-title":"Protein Cell"},{"key":"68490_CR58","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","volume":"37","author":"LM McLane","year":"2019","unstructured":"McLane, L. M. et al. CD8 T cell exhaustion during chronic viral infection and cancer. Annu. Rev. Immunol. 37, 457\u2013495 (2019).","journal-title":"Annu. Rev. Immunol."},{"key":"68490_CR59","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","volume":"19","author":"A Chow","year":"2022","unstructured":"Chow, A. et al. Clinical implications of T cell exhaustion for cancer immunotherapy. Nat. Rev. Clin. Oncol. 19, 775\u2013790 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"68490_CR60","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev-immunol-090222-110914","volume":"42","author":"A Baessler","year":"2024","unstructured":"Baessler, A. et al. T Cell Exhaustion. Annu. Rev. Immunol. 42, 179\u2013206 (2024).","journal-title":"Annu. Rev. Immunol."},{"key":"68490_CR61","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41590-022-01152-y","volume":"23","author":"TS Sumida","year":"2022","unstructured":"Sumida, T. S. et al. Type I interferon transcriptional network regulates expression of coinhibitory receptors in human T cells. Nat. Immunol. 23, 632\u2013642 (2022).","journal-title":"Nat. Immunol."},{"key":"68490_CR62","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41590-024-01755-7","volume":"25","author":"T Wertheimer","year":"2024","unstructured":"Wertheimer, T. et al. IL-23 stabilizes an effector Treg cell program in the tumor microenvironment. Nat. Immunol. 25, 512\u2013524 (2024).","journal-title":"Nat. Immunol."},{"key":"68490_CR63","doi-asserted-by":"crossref","first-page":"eadh9879","DOI":"10.1126\/sciadv.adh9879","volume":"9","author":"S Kang","year":"2023","unstructured":"Kang, S. et al. Engineered IL-7 synergizes with IL-12 immunotherapy to prevent T cell exhaustion and promote memory without exacerbating toxicity. Sci. Adv. 9, eadh9879 (2023).","journal-title":"Sci. Adv."},{"key":"68490_CR64","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/s41590-024-01896-9","volume":"25","author":"CC Zebley","year":"2024","unstructured":"Zebley, C. C. et al. T cell dysfunction and therapeutic intervention in cancer. Nat. Immunol. 25, 1344\u20131354 (2024).","journal-title":"Nat. Immunol."},{"key":"68490_CR65","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3390\/cancers15030682","volume":"15","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Efficacy and safety of PD-1\/PD-L1 checkpoint inhibitors versus anti-PD-1\/PD-L1 combined with other therapies for tumors: a systematic review. Cancers 15, 682 (2023).","journal-title":"Cancers"},{"key":"68490_CR66","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1021\/acsnano.2c11965","volume":"17","author":"PHD Nguyen","year":"2023","unstructured":"Nguyen, P. H. D. et al. Advances in drug delivery systems based on red blood cells and their membrane-derived nanoparticles. ACS Nano 17, 5187\u20135210 (2023).","journal-title":"ACS Nano"},{"key":"68490_CR67","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1039\/C8MH01554F","volume":"6","author":"M Zhang","year":"2019","unstructured":"Zhang, M. et al. Radiation-assisted metal ion interference tumor therapy by barium peroxide-based nanoparticles. Mater. Horiz. 6, 1034\u20131040 (2019).","journal-title":"Mater. Horiz."},{"key":"68490_CR68","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1039\/D2TB00028H","volume":"10","author":"T Basu","year":"2022","unstructured":"Basu, T. et al. Cross-linker-free sodium alginate and gelatin hydrogels: a multiscale biomaterial design framework. J. Mater. Chem. B 10, 3614\u20133623 (2022).","journal-title":"J. Mater. Chem. B"},{"key":"68490_CR69","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1007\/s00262-021-03001-7","volume":"70","author":"SL McArdel","year":"2021","unstructured":"McArdel, S. L. et al. Anti-tumor effects of RTX-240: an engineered red blood cell expressing 4-1BB ligand and interleukin-15. Cancer Immunol. Immunother. 70, 2701\u20132719 (2021).","journal-title":"Cancer Immunol. Immunother."},{"key":"68490_CR70","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic. Nat. Commun. 12, 2637 (2021).","journal-title":"Nat. Commun."},{"key":"68490_CR71","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.apsb.2021.10.018","volume":"12","author":"M Robert","year":"2022","unstructured":"Robert, M. et al. Multiparametric characterization of red blood cell physiology after hypotonic dialysis based drug encapsulation process. Acta Pharm. Sin. B 12, 2089\u20132102 (2022).","journal-title":"Acta Pharm. Sin. B"},{"key":"68490_CR72","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s41551-021-00712-1","volume":"5","author":"Q Hu","year":"2021","unstructured":"Hu, Q. et al. Inhibition of post-surgery tumour recurrence via a hydrogel releasing CAR-T cells and anti-PDL1-conjugated platelets. Nat. Biomed. Eng. 5, 1038\u20131047 (2021).","journal-title":"Nat. Biomed. Eng."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68490-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68490-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68490-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T14:55:48Z","timestamp":1771426548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68490-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68490"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-68490-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1784"}}